<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36509178</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Objective Hemodynamic Cardiovascular Autonomic Abnormalities in Post-Acute Sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>767</StartPage><EndPage>775</EndPage><MedlinePgn>767-775</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2022.12.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(22)01091-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many COVID-19 patients are left with symptoms several months after resolution of the acute illness; this syndrome is known as post-acute sequalae of COVID-19 (PASC). We aimed to determine the prevalence of objective hemodynamic cardiovascular autonomic abnormalities (CAA), explore sex differences, and assess the prevalence of CAA among hospitalized vs nonhospitalized patients with PASC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with PASC (n&#xa0;= 70; female [F]&#xa0;= 56; 42 years of age; 95% confidence interval [CI], 40-48) completed standard autonomic tests, including an active stand test 399 days (338, 455) after their COVID-19 infection. Clinical autonomic abnormalities were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most patients with PASC met the criteria for at least 1 CAA (51; 73%; F&#xa0;= 43). The postural orthostatic tachycardia syndrome hemodynamic (POTS<sub>HR</sub>) criterion of a heart rate increase of &gt; 30 beats per minute within 5 to 10 minutes of standing was seen in 21 patients (30%; F&#xa0;= 20; P&#xa0;= 0.037 [by sex]). The initial orthostatic hypotension hemodynamic (IOH<sub>40</sub>) criterion of a transient systolic blood pressure change of &gt; 40 mm Hg in the first 15 seconds of standing was seen in 43 (61%) patients and equally among female and male patients (63% vs 57%; P&#xa0;= 0.7). Only 9 (13%) patients were hospitalized; hospitalized vs nonhospitalized patients had similar frequencies of abnormalities (67% vs 74%; P&#xa0;= 0.7).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with PASC have evidence of CAA, most commonly IOH<sub>40</sub>, which will be missed unless an active stand test is used. Female patients have increased frequency of POTS<sub>HR</sub>, but IOH<sub>40</sub> is equally prevalent between sexes. Finally, even nonhospitalized "mild" infections can result in long-term CAAs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hira</LastName><ForeName>Rashmin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Jacquie R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddiqui</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranada</LastName><ForeName>Shaun I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soroush</LastName><ForeName>Ateyeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karalasingham</LastName><ForeName>Kavithra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Hyeqa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mavai</LastName><ForeName>Vibhuti</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala Valani</LastName><ForeName>Luciano Martin</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambreen</LastName><ForeName>Sakina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourne</LastName><ForeName>Kate M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Matthew G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillo</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheldon</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Satish R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Vanderbilt Autonomic Dysfunction Center, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: satish.raj@ucalgary.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian Long COVID Autonomic Network (CanLoCAN)</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Cardiol. 2023 Nov;39(11):1732. doi: 10.1016/j.cjca.2023.09.005</RefSource><PMID Version="1">37741631</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="Y">Cardiovascular System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007024" MajorTopicYN="Y">Hypotension, Orthostatic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="CONTEXTE">De nombreux patients ayant contract&#xe9; la COVID-19 pr&#xe9;sentent toujours des sympt&#xf4;mes plusieurs mois apr&#xe8;s la phase aigu&#xeb; de la maladie; on parle alors du syndrome post-COVID-19. L&#x2019;&#xe9;tude visait &#xe0; &#xe9;tablir objectivement la pr&#xe9;valence des anomalies h&#xe9;modynamiques de la fonction autonome cardiovasculaire (AHFAC), notamment chez les patients hospitalis&#xe9;s et non hospitalis&#xe9;s pr&#xe9;sentant le syndrome post-COVID-19, et &#xe0; d&#xe9;terminer s&#x2019;il y a des diff&#xe9;rences entre les sexes.</AbstractText><AbstractText Label="M&#xc9;THODOLOGIE">Des patients atteints du syndrome post-COVID-19 (n&#xa0;= 70; femmes [F]&#xa0;= 56; &#xe2;ge moyen&#xa0;= 42 ans; intervalle de confiance [IC] &#xe0; 95 % : 40 &#xe0; 48) se sont soumis &#xe0; des tests standard de la fonction autonome, notamment &#xe0; un test d&#x2019;orthostatisme, 399 jours (338, 455) apr&#xe8;s l&#x2019;infection par le virus de la COVID-19, qui visaient &#xe0; &#xe9;valuer les anomalies cliniques.</AbstractText><AbstractText Label="R&#xc9;SULTATS">La plupart des patients pr&#xe9;sentant le syndrome post-COVID-19 satisfaisaient aux crit&#xe8;res d&#xe9;finissant au moins une AHFAC (51; 73 %; F&#xa0;= 43). Un syndrome de tachycardie orthostatique posturale (STOP<sub>FC</sub>), soit une augmentation de la fr&#xe9;quence cardiaque (FC) de plus de 30 battements par minute apr&#xe8;s une p&#xe9;riode de 5 &#xe0; 10 minutes en position debout, a &#xe9;t&#xe9; observ&#xe9; chez 21 patients (30 %; F&#xa0;= 20; <i>p</i>&#xa0;= 0,037 [par sexe]). Une hypotension orthostatique initiale (HOI<sub>40</sub>), soit une variation transitoire de la pression art&#xe9;rielle systolique sup&#xe9;rieure &#xe0; 40 mmHg dans les 15 secondes suivant la mise en position debout, a &#xe9;t&#xe9; observ&#xe9;e chez 43 (61 %) patients, aussi bien des hommes que des femmes (63 % c. 57 %; <i>p</i>&#xa0;= 0,7). Seulement neuf (13 %) patients avaient &#xe9;t&#xe9; hospitalis&#xe9;s, et les anomalies &#xe9;taient aussi fr&#xe9;quentes chez les patients hospitalis&#xe9;s que chez les patients non hospitalis&#xe9;s (67 % c. 74 %; <i>p</i>&#xa0;= 0,7).</AbstractText><AbstractText Label="CONCLUSIONS">Les patients pr&#xe9;sentant le syndrome post-COVID-19 montraient des signes d&#x2019;AHFAC, le plus souvent une HOI<sub>40</sub>, qui risquent de passer inaper&#xe7;us si un test d&#x2019;orthostatisme n&#x2019;est pas r&#xe9;alis&#xe9;. Les femmes sont plus sujettes au STOP<sub>FC</sub>, mais l&#x2019;HOI<sub>40</sub> est tout aussi pr&#xe9;valente chez les hommes que chez les femmes. Enfin, m&#xea;me une infection &#xab; l&#xe9;g&#xe8;re &#xbb; n&#x2019;ayant pas n&#xe9;cessit&#xe9; d&#x2019;hospitalisation peut entra&#xee;ner des AHFAC &#xe0; long terme.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36509178</ArticleId><ArticleId IdType="pmc">PMC9733966</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId><ArticleId IdType="pii">S0828-282X(22)01091-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/ Available at:</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020. https://www.nice.org.uk/guidance/ng188 Published 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson I., Ramanathan K., Aurora R., et al. Long COVID-19: a primer for cardiovascular health professionals, on behalf of the CCS rapid response team. Can J Cardiol. 2021;37:1260&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180343</ArticleId><ArticleId IdType="pubmed">34090980</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M., Reistam U., Fedorowski A., et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134:1451&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M., St&#xe5;hlberg M., Runold M., et al. Long-haul post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K., Jamal S., Kichloo A., Grubb B.P. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J&#xa0;Innov Card Rhythm Manag. 2020;11:4302&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S.M., Landers D.B., Hollenberg S.M., et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J&#xa0;Am Coll Cardiol. 2022;79:2325&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Das SR, Addison D, et al. 2022 AHA / ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation. 2022;80:388&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222652</ArticleId><ArticleId IdType="pubmed">35753858</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall N., James S., Kavi L. Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients. Br J Cardiol. 2022;29:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196071</ArticleId><ArticleId IdType="pubmed">35747313</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J., Bazan V., Llad&#xf3;s G., et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan A., Jennings G., Xue F., Byrne L., Duggan E., Romero-Ortuno R. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural Orthostatic tachycardia syndrome. Front Physiol. 2022;13:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P., O&#x2019;Sullivan O., Houston A., et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. 2022;19:613&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldokla A.M., Ali S.T. Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance. Auton Neurosci. 2022;241</Citation><ArticleIdList><ArticleId IdType="pubmed">35679657</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms M.P.M., Finucane C., P&#xe9;rez-Denia L., et al. Systemic and cerebral circulatory adjustment within the first 60 s after active standing: an integrative physiological view. Auton Neurosci Basic Clin. 2021;231</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103784</ArticleId><ArticleId IdType="pubmed">33385733</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane C., van Wijnen V.K., Fan C.W., et al. A&#xa0;practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring. Clin Auton Res. 2019;29:427&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">31076939</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheshire W.P., Freeman R., Gibbons C.H., et al. Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021;132:666&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">33419664</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition. Published December 16, 2021. Available at: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition. Accessed May 31, 2022.</Citation></Reference><Reference><Citation>Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap):- a metadata-driven methodology and workflow process for providing translational research informatics support. J&#xa0;Biomed Inf. 2009;42:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Hamrefors V., Sutton R., et al. Do we need to evaluate diastolic blood pressure in patients with suspected orthostatic hypotension? Clin Auton Res. 2017;27:167&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5440543</ArticleId><ArticleId IdType="pubmed">28243824</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold A.C., Ng J., Lei L., Raj S.R. Autonomic dysfunction in cardiology: pathophysiology, investigation, and management. Can J Cardiol. 2017;33:1524&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705288</ArticleId><ArticleId IdType="pubmed">29102451</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R., Wieling W., Axelrod F.B., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Aut Res. 2011;21:69&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21431947</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Guzman J.C., Harvey P., et al. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020;36:357&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh N., Phillips A.A., Ranada S., et al. Mitigating initial orthostatic hypotension: mechanistic roles of muscle contraction versus sympathetic activation. Hypertension. 2022;79:638&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828707</ArticleId><ArticleId IdType="pubmed">34990207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon R.S., Grubb B.P., Olshansky B., et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41&#x2013;e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Quantitative autonomic testing. J&#xa0;Vis Exp. 2011;53:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196175</ArticleId><ArticleId IdType="pubmed">21788940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten D.M., Suarez G.A., Low P.A., Mandrekar J., Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kpaeyeh A., Mar P., Raj V., et al. Hemodynamic profiles and tolerability of modafinil in the treatment of POTS: a randomized placebo-controlled trial. J&#xa0;Clin Psychopharmacol. 2014;34:738&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239166</ArticleId><ArticleId IdType="pubmed">25222185</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Black B.K., Biaggioni I., Harris P.A., Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111:2734&#x2013;2740.</Citation><ArticleIdList><ArticleId IdType="pubmed">15911704</ArticleId></ArticleIdList></Reference><Reference><Citation>Green E., Black B., Biaggioni I., et al. Melatonin reduces tachycardia in postural tachycardia syndrome (POTS): a randomized, crossover trial. Cardiovasc Ther. 2014;32:105&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999238</ArticleId><ArticleId IdType="pubmed">24495468</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane C., O&#x2019;Connell M.D.L., Fan C.W., et al. Age-related normative changes in phasic orthostatic blood pressure in a large population study: findings from the Irish longitudinal study on ageing (TILDA) Circulation. 2014;130:1780&#x2013;1789.</Citation><ArticleIdList><ArticleId IdType="pubmed">25278101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieling W., Krediet C.T.P., Van Dijk N., Linzer M., Tschakovsky M.E. Initial orthostatic hypotension: review of a forgotten condition. Clin Sci. 2007;112:157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">17199559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh N.A., Ranada S., Lloyd M., et al. Lower body muscle preactivation and tensing mitigate symptoms of initial orthostatic hypotension in young females. Heart Rhythm. 2022;19:604&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">35365286</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamec I., Crno&#x161;ija L., Ru&#x161;ka B., et al. The incidence of postural orthostatic tachycardia syndrome in the population of Zagreb, Croatia. Croat Med J. 2020;61:422&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684539</ArticleId><ArticleId IdType="pubmed">33150760</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B.H., Stiles L.E., Bourne K., et al. The face of postural tachycardia syndrome: insights from a large cross-sectional online community-based survey. J&#xa0;Intern Med. 2019;286:438&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>van Twist D.J.L., Dinh T., Bouwmans E.M.E., Kroon A.A. Initial orthostatic hypotension among patients with unexplained syncope: an overlooked diagnosis? Int J Cardiol. 2018;271:269&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">30223355</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R. Postural tachycardia syndrome (POTS) Circulation. 2013;127:2336&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756553</ArticleId><ArticleId IdType="pubmed">23753844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagai K., Song Y., Ling J.F., et al. Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J&#xa0;Clin Sleep Med. 2011;7:204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077350</ArticleId><ArticleId IdType="pubmed">21509337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R.E.Y., Khan F.M., Hockin B.C.D., Lobban T.C.A., Sanatani S., Claydon V.E. Faintly tired: a systematic review of fatigue in patients with orthostatic syncope. Clin Auton Res. 2022;32:185&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9186485</ArticleId><ArticleId IdType="pubmed">35689118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci J.A., Chee E., Lorandeau A.L., Berger J. Fatigue in the US workforce: prevalence and implications for lost productive work time. J&#xa0;Occup Env Med. 2007;49:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">17215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28:67&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28730326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Kem D.C., Reim S., et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59(2 suppl 1):402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3275920</ArticleId><ArticleId IdType="pubmed">22215709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu X., Liles C., et al. Autoimmune basis for postural tachycardia syndrome. J&#xa0;Am Heart Assoc. 2014;3:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Li H., Yu X., et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19:1211&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834103</ArticleId><ArticleId IdType="pubmed">27702852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>